Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11845698 [patent_doc_number] => 09733249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'MPL mutations in JAK2 V617F negative patients with myeloproliferative disease' [patent_app_type] => utility [patent_app_number] => 14/492822 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11343 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492822 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/492822
MPL mutations in JAK2 V617F negative patients with myeloproliferative disease Sep 21, 2014 Issued
Array ( [id] => 11401750 [patent_doc_number] => 20170022288 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-01-26 [patent_title] => 'PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS' [patent_app_type] => utility [patent_app_number] => 14/492408 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492408 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/492408
PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS Sep 21, 2014 Abandoned
Array ( [id] => 11401750 [patent_doc_number] => 20170022288 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-01-26 [patent_title] => 'PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS' [patent_app_type] => utility [patent_app_number] => 14/492408 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492408 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/492408
PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS Sep 21, 2014 Abandoned
Array ( [id] => 10202744 [patent_doc_number] => 20150087728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 14/491446 [patent_app_country] => US [patent_app_date] => 2014-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31089 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491446 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/491446
COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER Sep 18, 2014 Abandoned
Array ( [id] => 11016801 [patent_doc_number] => 20160213754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'TRANSGLUTAMINASE 4 AS A PROSTATE SPECIFIC AUTOANTIGEN AND THE METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/023434 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10133 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023434 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/023434
TRANSGLUTAMINASE 4 AS A PROSTATE SPECIFIC AUTOANTIGEN AND THE METHODS OF USE THEREOF Sep 17, 2014 Abandoned
Array ( [id] => 9792215 [patent_doc_number] => 20150004159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'SCREENING FOR ANTI-CANCER COMPOUNDS USING NETRIN-1 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/486124 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17485 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486124 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/486124
SCREENING FOR ANTI-CANCER COMPOUNDS USING NETRIN-1 ACTIVITY Sep 14, 2014 Abandoned
Array ( [id] => 16742029 [patent_doc_number] => 10966998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Cancer therapy via a combination of epigenetic modulation and immune modulation [patent_app_type] => utility [patent_app_number] => 14/916235 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 22820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916235 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/916235
Cancer therapy via a combination of epigenetic modulation and immune modulation Sep 4, 2014 Issued
Array ( [id] => 11054474 [patent_doc_number] => 20160251437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'METHODS FOR TREATING CANCER IN PATIENTS WITH ELEVATED LEVELS OF BIM' [patent_app_type] => utility [patent_app_number] => 15/026461 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13037 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026461 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/026461
Methods for treating cancer in patients with elevated levels of BIM Sep 2, 2014 Issued
Array ( [id] => 13287711 [patent_doc_number] => 10155028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-18 [patent_title] => Method for prophylaxis and/or treatment of ErbB2 positive cancers [patent_app_type] => utility [patent_app_number] => 14/913515 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18096 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913515 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/913515
Method for prophylaxis and/or treatment of ErbB2 positive cancers Aug 19, 2014 Issued
Array ( [id] => 11002538 [patent_doc_number] => 20160199487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'MODULATION OF TUMOR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 14/912733 [patent_app_country] => US [patent_app_date] => 2014-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15425 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912733 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/912733
Modulation of tumor immunity Aug 17, 2014 Issued
Array ( [id] => 14759533 [patent_doc_number] => 10391146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-27 [patent_title] => Method to functionalize cells in human blood, other fluids and tissues using nanoparticles [patent_app_type] => utility [patent_app_number] => 14/909523 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909523 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/909523
Method to functionalize cells in human blood, other fluids and tissues using nanoparticles Aug 3, 2014 Issued
Array ( [id] => 9896180 [patent_doc_number] => 20150051379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'METHOD FOR TREATING SYNOVIAL SARCOMA' [patent_app_type] => utility [patent_app_number] => 14/447122 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29447 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447122 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/447122
Method for treating synovial sarcoma Jul 29, 2014 Issued
Array ( [id] => 10926227 [patent_doc_number] => 20140329248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'B7-H1 AND SURVIVIN IN CANCER' [patent_app_type] => utility [patent_app_number] => 14/328367 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328367 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/328367
B7-H1 AND SURVIVIN IN CANCER Jul 9, 2014 Abandoned
Array ( [id] => 10800683 [patent_doc_number] => 20160146840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'AUGURIN IMMUNOASSAY' [patent_app_type] => utility [patent_app_number] => 14/903893 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11462 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903893 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/903893
Augurin immunoassay Jul 9, 2014 Issued
Array ( [id] => 9798641 [patent_doc_number] => 20150010585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'IMMUNOCONJUGATES TARGETING SYNDECAN-1 EXPRESSING CELLS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/327888 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14311 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327888 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/327888
IMMUNOCONJUGATES TARGETING SYNDECAN-1 EXPRESSING CELLS AND USE THEREOF Jul 9, 2014 Abandoned
Array ( [id] => 12166950 [patent_doc_number] => 09885718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Specific biomarker set for non-invasive diagnosis of liver cancer' [patent_app_type] => utility [patent_app_number] => 14/321870 [patent_app_country] => US [patent_app_date] => 2014-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 5373 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321870 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/321870
Specific biomarker set for non-invasive diagnosis of liver cancer Jul 1, 2014 Issued
Array ( [id] => 11298921 [patent_doc_number] => 09506925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Specific biomarker set for non-invasive diagnosis of liver cancer' [patent_app_type] => utility [patent_app_number] => 14/321867 [patent_app_country] => US [patent_app_date] => 2014-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 5372 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321867 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/321867
Specific biomarker set for non-invasive diagnosis of liver cancer Jul 1, 2014 Issued
Array ( [id] => 9771798 [patent_doc_number] => 20140295459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'MARKERS FOR IDENTIFYING TUMOR CELLS, METHODS AND KIT THEREOF' [patent_app_type] => utility [patent_app_number] => 14/304432 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15791 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14304432 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/304432
MARKERS FOR IDENTIFYING TUMOR CELLS, METHODS AND KIT THEREOF Jun 12, 2014 Abandoned
Array ( [id] => 9737500 [patent_doc_number] => 20140273217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'PRODRUG ACTIVATION IN CANCER CELLS USING MOLECULAR SWITCHES' [patent_app_type] => utility [patent_app_number] => 14/291925 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27497 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291925 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/291925
Prodrug activation in cancer cells using molecular switches May 29, 2014 Issued
Array ( [id] => 10763300 [patent_doc_number] => 20160109455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY' [patent_app_type] => utility [patent_app_number] => 14/890091 [patent_app_country] => US [patent_app_date] => 2014-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 23092 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890091 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/890091
COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY May 7, 2014 Abandoned
Menu